Serial Number:
97560311
Mark:
OLIBDY
Status:
First Extension-Granted
Status Date:
05-13-2024
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer Diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use Health care services, namely, disease management programs; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to medical treatment recommendation; medical consultation; providing a website featuring information about medical services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; medical diagnostic testing provided by medical laboratories; medical analysis services in the nature of laboratory testing for disease management and patient diagnosis and patient selection for the diagnosis and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, provided by medical laboratories; medical analysis services relating to the treatment of patients in the nature of laboratory testing for the purpose of immune modulation and management of side effects associated with renal disorders and cancer, provided by medical laboratories Medical laboratory services, namely, laboratory testing for scientific research purposes and medical research services; medical laboratory services, namely, laboratory testing for scientific research purposes in the field of disease management and gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; medical laboratory services, namely, laboratory testing for scientific research of immune modulation and management of side effects associated with renal disorders and cancer pathology; medical laboratory services, namely, laboratory testing for scientific research of patient disease diagnoses and for patient selection for clinical trials
Mark Description:
N/A
Class:
Medical services
Type of Mark:
Trademark
Published for Opposition Date:
10-10-2023
Owner:
Mark Drawing Status:
4
Abandon Date:
N/A
Business Name:
126 E. LINCOLN AVENUE
Correspondent Name:
